One potential driver is the expression of RNASE6, which encodes an antimicrobial peptide and has been linked to AD-related inflammatory genes, since it was recently shown to associate with worse memory in APOE4 carriers and express at higher levels in the DLPFC of persons with AD [36–38]. This evidence concerns the gene APOE and Alzheimer disease.